Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab + Lenalidomide vs Rituximab + Chemotherapy in Elderly Relapsed DLBCL
NCT04113226Phase 2Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Nov 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in diffuse large B-cell lymphoma (DLBCL), sponsored by CHU Amiens-Picardie. Started Nov 2021; status: completed.
02
Drugs
lenalidomide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT04113226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04113226.